Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 5453 entries
Sorted by: Best Match Show Resources per page
Atypical hemolytic uremic syndrome post-kidney transplantation: two case reports and review of the literature.

Frontiers in medicine

Alasfar S, Alachkar N.
PMID: 25593925
Front Med (Lausanne). 2014 Dec 12;1:52. doi: 10.3389/fmed.2014.00052. eCollection 2014.

Atypical hemolytic uremic syndrome (aHUS) is a rare disorder characterized by over-activation and dysregulation of the alternative complement pathway. Its estimated prevalence is 1-2 per million. The disease is characterized by thrombotic microangiopathy, which causes anemia, thrombocytopenia, and acute...

Cite
Alasfar S, Alachkar N. Atypical hemolytic uremic syndrome post-kidney transplantation: two case reports and review of the literature. Front Med (Lausanne). 2014;1:52doi: 10.3389/fmed.2014.00052.
Alasfar, S., & Alachkar, N. (2014). Atypical hemolytic uremic syndrome post-kidney transplantation: two case reports and review of the literature. Frontiers in medicine, 152. https://doi.org/10.3389/fmed.2014.00052
Alasfar, Sami, and Alachkar, Nada. "Atypical hemolytic uremic syndrome post-kidney transplantation: two case reports and review of the literature." Frontiers in medicine vol. 1 (2014): 52. doi: https://doi.org/10.3389/fmed.2014.00052
Alasfar S, Alachkar N. Atypical hemolytic uremic syndrome post-kidney transplantation: two case reports and review of the literature. Front Med (Lausanne). 2014 Dec 12;1:52. doi: 10.3389/fmed.2014.00052. eCollection 2014. PMID: 25593925; PMCID: PMC4292050.
Copy Download .nbib Format: NLM
Male Sexual Dysfunction and Chronic Kidney Disease.

Frontiers in medicine

Edey MM.
PMID: 28382300
Front Med (Lausanne). 2017 Mar 22;4:32. doi: 10.3389/fmed.2017.00032. eCollection 2017.

Male sexual dysfunction is common in chronic kidney disease (CKD), particularly in end-stage renal disease. Historically, this cause of considerable morbidity has been under-reported and under-recognized. The ideal approach to diagnosis and management remains unclear due to a paucity...

Cite
Edey MM. Male Sexual Dysfunction and Chronic Kidney Disease. Front Med (Lausanne). 2017;4:32doi: 10.3389/fmed.2017.00032.
Edey, M. M. (2017). Male Sexual Dysfunction and Chronic Kidney Disease. Frontiers in medicine, 432. https://doi.org/10.3389/fmed.2017.00032
Edey, Matthew M. "Male Sexual Dysfunction and Chronic Kidney Disease." Frontiers in medicine vol. 4 (2017): 32. doi: https://doi.org/10.3389/fmed.2017.00032
Edey MM. Male Sexual Dysfunction and Chronic Kidney Disease. Front Med (Lausanne). 2017 Mar 22;4:32. doi: 10.3389/fmed.2017.00032. eCollection 2017. PMID: 28382300; PMCID: PMC5360730.
Copy Download .nbib Format: NLM
Call for an Evidence-Based Consensus on Outcome Reporting in Tinnitus Intervention Studies.

Frontiers in medicine

Londero A, Hall DA.
PMID: 28484698
Front Med (Lausanne). 2017 Apr 21;4:42. doi: 10.3389/fmed.2017.00042. eCollection 2017.

No abstract available.

Cite
Londero A, Hall DA. Call for an Evidence-Based Consensus on Outcome Reporting in Tinnitus Intervention Studies. Front Med (Lausanne). 2017;4:42doi: 10.3389/fmed.2017.00042.
Londero, A., & Hall, D. A. (2017). Call for an Evidence-Based Consensus on Outcome Reporting in Tinnitus Intervention Studies. Frontiers in medicine, 442. https://doi.org/10.3389/fmed.2017.00042
Londero, Alain, and Hall, Deborah A. "Call for an Evidence-Based Consensus on Outcome Reporting in Tinnitus Intervention Studies." Frontiers in medicine vol. 4 (2017): 42. doi: https://doi.org/10.3389/fmed.2017.00042
Londero A, Hall DA. Call for an Evidence-Based Consensus on Outcome Reporting in Tinnitus Intervention Studies. Front Med (Lausanne). 2017 Apr 21;4:42. doi: 10.3389/fmed.2017.00042. eCollection 2017. PMID: 28484698; PMCID: PMC5399023.
Copy Download .nbib Format: NLM
Second-line Treatment of Non-Small Cell Lung Cancer: Focus on the Clinical Development of Dacomitinib.

Frontiers in medicine

Zugazagoitia J, Díaz A, Jimenez E, Nuñez JA, Iglesias L, Ponce-Aix S, Paz-Ares L.
PMID: 28424775
Front Med (Lausanne). 2017 Apr 05;4:36. doi: 10.3389/fmed.2017.00036. eCollection 2017.

Dacomitinib is a second-generation, irreversible, covalent pan-HER tyrosine-kinase inhibitor (TKI). It showed potent EGFR signaling inhibition in experimental models, including first-generation TKI-resistant non-small cell lung cancer (NSCLC) cell lines. This preclinical efficacy did not translate into clinically meaningful treatment...

Cite
Zugazagoitia J, Díaz A, Jimenez E, et al. Second-line Treatment of Non-Small Cell Lung Cancer: Focus on the Clinical Development of Dacomitinib. Front Med (Lausanne). 2017;4:36doi: 10.3389/fmed.2017.00036.
Zugazagoitia, J., Díaz, A., Jimenez, E., Nuñez, J. A., Iglesias, L., Ponce-Aix, S., & Paz-Ares, L. (2017). Second-line Treatment of Non-Small Cell Lung Cancer: Focus on the Clinical Development of Dacomitinib. Frontiers in medicine, 436. https://doi.org/10.3389/fmed.2017.00036
Zugazagoitia, Jon, et al. "Second-line Treatment of Non-Small Cell Lung Cancer: Focus on the Clinical Development of Dacomitinib." Frontiers in medicine vol. 4 (2017): 36. doi: https://doi.org/10.3389/fmed.2017.00036
Zugazagoitia J, Díaz A, Jimenez E, Nuñez JA, Iglesias L, Ponce-Aix S, Paz-Ares L. Second-line Treatment of Non-Small Cell Lung Cancer: Focus on the Clinical Development of Dacomitinib. Front Med (Lausanne). 2017 Apr 05;4:36. doi: 10.3389/fmed.2017.00036. eCollection 2017. PMID: 28424775; PMCID: PMC5380728.
Copy Download .nbib Format: NLM
Tissue Biomarkers in Hepatocellular Tumors: Which, When, and How.

Frontiers in medicine

Di Tommaso L, Roncalli M.
PMID: 28280721
Front Med (Lausanne). 2017 Feb 23;4:10. doi: 10.3389/fmed.2017.00010. eCollection 2017.

Few tissue markers are currently available to pathologists in the study of hepatocellular tumors. These markers should be used carefully taking into consideration not only morphology but also, and sometimes even more important, the clinical setting where the lesion...

Cite
Di Tommaso L, Roncalli M. Tissue Biomarkers in Hepatocellular Tumors: Which, When, and How. Front Med (Lausanne). 2017;4:10doi: 10.3389/fmed.2017.00010.
Di Tommaso, L., & Roncalli, M. (2017). Tissue Biomarkers in Hepatocellular Tumors: Which, When, and How. Frontiers in medicine, 410. https://doi.org/10.3389/fmed.2017.00010
Di Tommaso, Luca, and Roncalli, Massimo. "Tissue Biomarkers in Hepatocellular Tumors: Which, When, and How." Frontiers in medicine vol. 4 (2017): 10. doi: https://doi.org/10.3389/fmed.2017.00010
Di Tommaso L, Roncalli M. Tissue Biomarkers in Hepatocellular Tumors: Which, When, and How. Front Med (Lausanne). 2017 Feb 23;4:10. doi: 10.3389/fmed.2017.00010. eCollection 2017. PMID: 28280721; PMCID: PMC5322593.
Copy Download .nbib Format: NLM
Exercise-Associated Hyponatremia: 2017 Update.

Frontiers in medicine

Hew-Butler T, Loi V, Pani A, Rosner MH.
PMID: 28316971
Front Med (Lausanne). 2017 Mar 03;4:21. doi: 10.3389/fmed.2017.00021. eCollection 2017.

Exercise-associated hyponatremia (EAH) was initially described in the 1980s in endurance athletes, and work done since then has conclusively identified that overdrinking beyond thirst and non-osmotic arginine vasopressin release are the most common etiologic factors. In recent years, EAH...

Cite
Hew-Butler T, Loi V, Pani A, et al. Exercise-Associated Hyponatremia: 2017 Update. Front Med (Lausanne). 2017;4:21doi: 10.3389/fmed.2017.00021.
Hew-Butler, T., Loi, V., Pani, A., & Rosner, M. H. (2017). Exercise-Associated Hyponatremia: 2017 Update. Frontiers in medicine, 421. https://doi.org/10.3389/fmed.2017.00021
Hew-Butler, Tamara, et al. "Exercise-Associated Hyponatremia: 2017 Update." Frontiers in medicine vol. 4 (2017): 21. doi: https://doi.org/10.3389/fmed.2017.00021
Hew-Butler T, Loi V, Pani A, Rosner MH. Exercise-Associated Hyponatremia: 2017 Update. Front Med (Lausanne). 2017 Mar 03;4:21. doi: 10.3389/fmed.2017.00021. eCollection 2017. PMID: 28316971; PMCID: PMC5334560.
Copy Download .nbib Format: NLM
2D DIGE Does Not Reveal all: A Scotopic Report Suggests Differential Expression of a Single "Calponin Family Member" Protein for Tetany of Sphincters!.

Frontiers in medicine

Chaudhury A.
PMID: 26151053
Front Med (Lausanne). 2015 Jun 18;2:42. doi: 10.3389/fmed.2015.00042. eCollection 2015.

Using 2D differential gel electrophoresis (DIGE) and mass spectrometry (MS), a recent report by Rattan and Ali (2015) compared proteome expression between tonically contracted sphincteric smooth muscles of the internal anal sphincter (IAS), in comparison to the adjacent rectum...

Cite
Chaudhury A. 2D DIGE Does Not Reveal all: A Scotopic Report Suggests Differential Expression of a Single "Calponin Family Member" Protein for Tetany of Sphincters!. Front Med (Lausanne). 2015;2:42doi: 10.3389/fmed.2015.00042.
Chaudhury, A. (2015). 2D DIGE Does Not Reveal all: A Scotopic Report Suggests Differential Expression of a Single "Calponin Family Member" Protein for Tetany of Sphincters!. Frontiers in medicine, 242. https://doi.org/10.3389/fmed.2015.00042
Chaudhury, Arun. "2D DIGE Does Not Reveal all: A Scotopic Report Suggests Differential Expression of a Single "Calponin Family Member" Protein for Tetany of Sphincters!." Frontiers in medicine vol. 2 (2015): 42. doi: https://doi.org/10.3389/fmed.2015.00042
Chaudhury A. 2D DIGE Does Not Reveal all: A Scotopic Report Suggests Differential Expression of a Single "Calponin Family Member" Protein for Tetany of Sphincters!. Front Med (Lausanne). 2015 Jun 18;2:42. doi: 10.3389/fmed.2015.00042. eCollection 2015. PMID: 26151053; PMCID: PMC4471425.
Copy Download .nbib Format: NLM
Treatment of Cirrhosis-Associated Hyponatremia with Midodrine and Octreotide.

Frontiers in medicine

Patel S, Nguyen DS, Rastogi A, Nguyen MK, Nguyen MK.
PMID: 28352627
Front Med (Lausanne). 2017 Mar 14;4:17. doi: 10.3389/fmed.2017.00017. eCollection 2017.

BACKGROUND: Hyponatremia in the setting of cirrhosis is a common electrolyte disorder with few therapeutic options. The free water retention is due to non-osmotic vasopressin secretion resulting from the cirrhosis-associated splanchnic vasodilatation. Therefore, vasoconstrictive therapy may correct this electrolyte...

Cite
Patel S, Nguyen DS, Rastogi A, et al. Treatment of Cirrhosis-Associated Hyponatremia with Midodrine and Octreotide. Front Med (Lausanne). 2017;4:17doi: 10.3389/fmed.2017.00017.
Patel, S., Nguyen, D. S., Rastogi, A., Nguyen, M. K., & Nguyen, M. K. (2017). Treatment of Cirrhosis-Associated Hyponatremia with Midodrine and Octreotide. Frontiers in medicine, 417. https://doi.org/10.3389/fmed.2017.00017
Patel, Sharad, et al. "Treatment of Cirrhosis-Associated Hyponatremia with Midodrine and Octreotide." Frontiers in medicine vol. 4 (2017): 17. doi: https://doi.org/10.3389/fmed.2017.00017
Patel S, Nguyen DS, Rastogi A, Nguyen MK, Nguyen MK. Treatment of Cirrhosis-Associated Hyponatremia with Midodrine and Octreotide. Front Med (Lausanne). 2017 Mar 14;4:17. doi: 10.3389/fmed.2017.00017. eCollection 2017. PMID: 28352627; PMCID: PMC5348528.
Copy Download .nbib Format: NLM
Cord Blood Banking Standards: Autologous Versus Altruistic.

Frontiers in medicine

Armitage S.
PMID: 26779485
Front Med (Lausanne). 2016 Jan 08;2:94. doi: 10.3389/fmed.2015.00094. eCollection 2015.

Cord blood (CB) is either donated to public CB banks for use by any patient worldwide for whom it is a match or stored in a private bank for potential autologous or family use. It is a unique cell...

Cite
Armitage S. Cord Blood Banking Standards: Autologous Versus Altruistic. Front Med (Lausanne). 2016;2:94doi: 10.3389/fmed.2015.00094.
Armitage, S. (2015). Cord Blood Banking Standards: Autologous Versus Altruistic. Frontiers in medicine, 294. https://doi.org/10.3389/fmed.2015.00094
Armitage, Sue. "Cord Blood Banking Standards: Autologous Versus Altruistic." Frontiers in medicine vol. 2 (2015): 94. doi: https://doi.org/10.3389/fmed.2015.00094
Armitage S. Cord Blood Banking Standards: Autologous Versus Altruistic. Front Med (Lausanne). 2016 Jan 08;2:94. doi: 10.3389/fmed.2015.00094. eCollection 2015. PMID: 26779485; PMCID: PMC4705863.
Copy Download .nbib Format: NLM
Cord Blood as a Source of Natural Killer Cells.

Frontiers in medicine

Mehta RS, Shpall EJ, Rezvani K.
PMID: 26779484
Front Med (Lausanne). 2016 Jan 05;2:93. doi: 10.3389/fmed.2015.00093. eCollection 2015.

Cord blood (CB) offers several unique advantages as a graft source for hematopoietic stem cell transplantation (HSCT). The risk of relapse and graft vs. host disease after cord blood transplantation (CBT) is lower than what is typically observed after...

Cite
Mehta RS, Shpall EJ, Rezvani K. Cord Blood as a Source of Natural Killer Cells. Front Med (Lausanne). 2016;2:93doi: 10.3389/fmed.2015.00093.
Mehta, R. S., Shpall, E. J., & Rezvani, K. (2015). Cord Blood as a Source of Natural Killer Cells. Frontiers in medicine, 293. https://doi.org/10.3389/fmed.2015.00093
Mehta, Rohtesh S, et al. "Cord Blood as a Source of Natural Killer Cells." Frontiers in medicine vol. 2 (2015): 93. doi: https://doi.org/10.3389/fmed.2015.00093
Mehta RS, Shpall EJ, Rezvani K. Cord Blood as a Source of Natural Killer Cells. Front Med (Lausanne). 2016 Jan 05;2:93. doi: 10.3389/fmed.2015.00093. eCollection 2015. PMID: 26779484; PMCID: PMC4700256.
Copy Download .nbib Format: NLM
The Effect of a Combination Treatment Using Palonosetron, Promethazine, and Dexamethasone on the Prophylaxis of Postoperative Nausea and Vomiting and QTc Interval Duration in Patients Undergoing Craniotomy under General Anesthesia: A Pilot Study.

Frontiers in medicine

Bergese SD, Puente EG, Antor MA, Capo G, Yildiz VO, Uribe AA.
PMID: 26870733
Front Med (Lausanne). 2016 Feb 02;3:1. doi: 10.3389/fmed.2016.00001. eCollection 2016.

INTRODUCTION: Postoperative nausea and vomiting (PONV) is a displeasing experience that distresses surgical patients during the first 24 h after a surgical procedure. The incidence of postoperative nausea occurs in about 50%, the incidence of postoperative vomiting is about...

Cite
Bergese SD, Puente EG, Antor MA, et al. The Effect of a Combination Treatment Using Palonosetron, Promethazine, and Dexamethasone on the Prophylaxis of Postoperative Nausea and Vomiting and QTc Interval Duration in Patients Undergoing Craniotomy under General Anesthesia: A Pilot Study. Front Med (Lausanne). 2016;3:1doi: 10.3389/fmed.2016.00001.
Bergese, S. D., Puente, E. G., Antor, M. A., Capo, G., Yildiz, V. O., & Uribe, A. A. (2016). The Effect of a Combination Treatment Using Palonosetron, Promethazine, and Dexamethasone on the Prophylaxis of Postoperative Nausea and Vomiting and QTc Interval Duration in Patients Undergoing Craniotomy under General Anesthesia: A Pilot Study. Frontiers in medicine, 31. https://doi.org/10.3389/fmed.2016.00001
Bergese, Sergio D, et al. "The Effect of a Combination Treatment Using Palonosetron, Promethazine, and Dexamethasone on the Prophylaxis of Postoperative Nausea and Vomiting and QTc Interval Duration in Patients Undergoing Craniotomy under General Anesthesia: A Pilot Study." Frontiers in medicine vol. 3 (2016): 1. doi: https://doi.org/10.3389/fmed.2016.00001
Bergese SD, Puente EG, Antor MA, Capo G, Yildiz VO, Uribe AA. The Effect of a Combination Treatment Using Palonosetron, Promethazine, and Dexamethasone on the Prophylaxis of Postoperative Nausea and Vomiting and QTc Interval Duration in Patients Undergoing Craniotomy under General Anesthesia: A Pilot Study. Front Med (Lausanne). 2016 Feb 02;3:1. doi: 10.3389/fmed.2016.00001. eCollection 2016. PMID: 26870733; PMCID: PMC4735400.
Copy Download .nbib Format: NLM
Surfactant Protein D in Respiratory and Non-Respiratory Diseases.

Frontiers in medicine

Sorensen GL.
PMID: 29473039
Front Med (Lausanne). 2018 Feb 08;5:18. doi: 10.3389/fmed.2018.00018. eCollection 2018.

Surfactant protein D (SP-D) is a multimeric collectin that is involved in innate immune defense and expressed in pulmonary, as well as non-pulmonary, epithelia. SP-D exerts antimicrobial effects and dampens inflammation through direct microbial interactions and modulation of host...

Cite
Sorensen GL. Surfactant Protein D in Respiratory and Non-Respiratory Diseases. Front Med (Lausanne). 2018;5:18doi: 10.3389/fmed.2018.00018.
Sorensen, G. L. (2018). Surfactant Protein D in Respiratory and Non-Respiratory Diseases. Frontiers in medicine, 518. https://doi.org/10.3389/fmed.2018.00018
Sorensen, Grith L. "Surfactant Protein D in Respiratory and Non-Respiratory Diseases." Frontiers in medicine vol. 5 (2018): 18. doi: https://doi.org/10.3389/fmed.2018.00018
Sorensen GL. Surfactant Protein D in Respiratory and Non-Respiratory Diseases. Front Med (Lausanne). 2018 Feb 08;5:18. doi: 10.3389/fmed.2018.00018. eCollection 2018. PMID: 29473039; PMCID: PMC5809447.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 5453 entries